 |
|
|
|
|
APDA Funded Research
|
|
|
George C. Cotzias, MD Memorial Fellowships
|
|
David Hinkle, MD, Ph.D.
University of Pittsburgh
Pittsburg, PA
|
The Potential Role of Antioxidant Systems in the Mechanism of DJ-1 Dependent Astrocytemediated Neuroprotection
|
|
|
|
Bradley Miller, MD, Ph.D.
University of Virginia
Charlottesville, VA
|
Distribution and Metabolic Consequences of Mitochondrial DNA Deletions in Substantia Nigra and Cultured Cells
|
|
|
|
Talene Yacoubian, MD, Ph.D.
The University of Alabama
Birmingham, Al
|
Role of 14-3-3 Proteins in Alpha Synuclein Induced Neurotoxicity
|
|
|
|
|
Roger C. Duvoisin, MD, Research Grant
|
|
Andrei Alexandrescu, Ph.D.
University of Connecticut
Storrs, CT
|
Stability and Solvent Accessibility of Alpha-Synuclein Fibrils by NMR Hydrogen Exchange
|
|
|
|
Jeffrey Stock, Ph.D.
Princeton University
Princeton, NJ
|
Protein Phosphatase 2A Methylation as a Therapeutic Target for Parkinson’s Disease
|
|
|
|
Marc Tatar, Ph.D.
Brown University
Providence, RI
|
Assessing the Pathogenic and Molecular Consequences of FOXO Regulation by Parkin
|
|
|
|
|
Research Grants
|
|
Hans Bueler, Ph.D.
University of Kentucky
Lexington, KY
|
Identification of PINK1 Substrates Using Conditional PINK1 Knockout Cells and Quantitative Phosphoproteomics
|
|
|
|
Ippolita Castelvetri, Ph.D.
Massachusetts General Hospital
Charlestown, MA
|
Biological Basis for Diferential Susceptibility to Alpha-Synuclein Pathology in the Male and Femal Human Brain
|
|
|
|
Savio Chan, Ph.D.
Northwestern University
Chicago, IL
|
Sriatopallidal GABAergic Signaling in Mouse Models of Parkinson’s Disease
|
|
|
|
Linan Chen, MD, Ph.D.
University of Chicago
Chicago, IL
|
Transgenic Overexpression Selectively in Dopamine Neurons via Controlled Genetic Amplification
|
|
|
|
Shu Chen, Ph.D.
Case Western Reserve University
Cleveland, OH
|
Transgenic C. Elegans Model of LRRK2-Linked Parkinson Disease
|
|
|
|
Shankar Chinta, Ph.D.
Buck Institute for Age Research
Novato, CA
|
Potential Neuroprotective Role of Resveratrol in Parkinson’s Disease Mouse Models
|
|
|
|
Paul Davenport, Ph.D.
University of Florida
Gainesville, FL
|
Central Neural Gating of Pharyngeal Mechanically Elicited Cortical Evoked Potentials (CEP): An Evaluation of Swallow Neural Integration in Parkinson’s Disease (PD)
|
|
|
|
Wei Ming Duan, MD, Ph.D.
Louisiana State University
Shreveport, LA
|
Generation of Dopaminergic Neurons from Endogenous Stem Cells in the Brain of a Mouse Model of Parkinson’s Disease
|
|
|
|
Jian Feng, Ph.D.
State University of New York
Buffalo, NY
|
Generating Patient –Specific Induced Pluripotent Stem Cells to Study Parkinson’s Disease
|
|
|
|
Matthew Goldberg, Ph.D.
UT Southwestern Medical Center
Dallas, TX
|
Parkin, DJ-1 and Glutathione Peroxidase-Deficient Mouse Models of PD
|
|
|
|
Steven Johnson, MD, Ph.D.
Portland VA Research
Portland, OR
|
Redox Regulation of NMDA Currents in Midbrain Dopamine Neurons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gerardo Morfini, Ph.D.
University of Illinois
Chicago, IL
|
Molecular Mechanisms Underlying MPP+ Induced Activation of Cytoplamic Dynein-Based Vesicle Transport
|
|
|
|
Anthony Nicholas, MD, Ph.D.
University of Alabama
Birmingham, AL
|
Gene Analysis of Histone Deacetylation in Levodopa-Induced Dyskinesia and Priming
|
|
|
|
Arnulfo Quesada, Ph.D.
Brentwood Biomedical Research Institute
Los Angeles, CA
|
A Promising New Protective Factor for Parkinson’s Disease
|
|
|
|
|
|
|
|
|
Jean Rochet, Ph.D.
Purdue University
West Lafayette, IN
|
Role of ATP13A2 (PARK9) Dysfunction in Parkinson’s Disease
|
|
|
|
Subhojit Roy, Ph.D.
University of California
Jolla, CA
|
Effects of Alpha-Synuclein on Fast and Slow Axonal Transport
|
|
|
|
Derek Siebruth, Ph.D.
University of Southern California
Los Angeles, CA
|
Large Scale Analysis of Synaptic Architecture in Alphasynuclein Expressing Neurons
|
|
|
|
Wanli Smith, MD, Ph.D.
Johns Hopkins University School of Med.
Baltimore, MD
|
Autophagy and LRRK2-Linked Parkinsonism
|
|
|
|
Shaji Theodore, Ph.D.
University of Alabama
Birmingham, AL
|
Inhibiting Nuclear Factor Kappa B Signaling and Microglial Activation in a Mouse Model of Parkinson’s Disease
|
|
|
|
Enrique Torre, Ph.D.
Emory University
Atlanta, GA
|
Significance of mRNA Transport and Translation within the Dopaminergic Axon
|
|
|
|
Kala Venkiteswaran, Ph.D.
Penn State Hershey College of Medicine
Hershey, PA
|
Transplantation of Transdifferentiated Dopaminergic Neurons Derived from Human Retinal Pigment Epithelial Cells
|
|
|
|
Harrison Walker, MD
University of Alabama
Birmingham, AL
|
Bilateral Clinical and Neurophysiological Effects of Unilateral STN DBS in PD
|
|
|
|
Gaofeng Wang, Ph.D.
University of Miami
Coral Gables, FL
|
The Role of miRNA in Olfactory Deficit of Parkinson’s Disease
|
|
|
|
Andrew West, Ph.D.
University of Alabama
Birmingham, AL
|
Development of Cell Based Kinase Assays for LRRK2
|
|
|
|
|
|
|
|
|
Fu-Ming Zhou, MD, Ph.D.
University of Tennessee
Memphis, TN
|
An Ultra Short Dopamine Pathway: Part II. Signaling Mechanisms
|
|
|
|
Jianhui Zhu, Ph.D.
University of Pittsburgh
Pittsburgh, PA
|
ATP13A2 and Autolysosomal Pathology in Parkinson’s Disease
|
|
|
|
Xiongwei Zhu, Ph.D.
Case Western Reserve University
Cleveland, OH
|
Role of Impaired Mitochondrial Dynamics in Mutant LRRK2 Induced Toxicity
|
|
|
|
|
|
|
|
|
|
Post-Doctoral Fellowships
|
|
Jason Cannon, Ph.D.
University of Pittsburgh
Pittsburgh, PA
|
Genetic and Environmental Interactions in Parkinson’s Disease: Potential for New Therapeutic Pathways
|
|
|
|
William Caudle, Ph.D.
University of Washington
Seattle, WA
|
Proteomic Analysis of VMAT2 under Normal and Pathological Conditions
|
|
|
|
Yeun Su Choo, Ph.D.
Burnham Institute for Medical Research
La Jolla, CA
|
Regulation of Parkin by Neddylation
|
|
|
|
|
|
|
|
|
Gizem Donmez, Ph.D.
Massachusetts Institute of Technology
Cambridge, MA
|
Analysis of the Role of SIRT2 Protein in Parkinson’s Disease
|
|
|
|
Robert Drolet, Ph.D.
University of Pittsburgh
Pittsburgh, PA
|
Gastrointestinal Dysfunction in the Rotenone Model of Parkinson’s Disease
|
|
|
|
Muralidhar Hedge, Ph.D.
Uiversity of Texas
Galveston, TX
|
Role of Transition Metals in Inhibiting Repair of Oxidized Bases in Genome: Relevance to Parkinson’s Disease
|
|
|
|
William Lin, Ph.D.
University of Chicago
Chicago, IL
|
Mechanism and Function of Cytosolic PINK1
|
|
|
|
Zhihui Sun, Ph.D.
University of Pennsylvania
Philadelphia, PA
|
Investigating Synuclein Gene FunctionIn Zebrafish
|
|
|
|
Daniel Tardiff, Ph.D.
Whitehead Institute for Biomedical Res.
Cambridge, MA
|
Mitochondrial Proteomics of a Yeast Parkinson’s Disease Model
|
|
|
|
Ravindar Thomas, Ph.D.
University of Virginia
Charlottesville, VA
|
Development of Mitochondrial Gene Therapy for Parkinson’s Disease
|
|
|
|
Yulan Xiong, Ph.D.
Johns Hopkins University
Baltimore, MD
|
Modeling LRRK2-Induced Toxicity in Yeast
|
|
|
|
Nanyan Zhang, Ph.D.
University of Colorado
Aurora, CO
|
Delineating Protein Coaggregation during Lewy Body Formation
|
|
|
|
|
Medical Students Summer Fellowships
|
|
Grant Aaker
Weill Cornell Medical College
New York, NY
|
Detection of Retinal Changes in PD with Optical Coherence
|
|
|
|
Shivraj Bhosle
Burke Medical Research Institute/Weill Cornell Medical College
New York, NY
|
Region Specific Regulation of Gene Expression in Dopamine Neurons
|
|
|
|
Nirmish Singla
University of Michigan Medical School
Ann Arbor, MI
|
Evaluation of Lead Placement in Deep Brain Stimulation with Post-op Cognitive and Behavioral Outcome
|
|
|
|
Minhong Yu
University of Virginia
Charlottesville, NC
|
Rhythmic Perception in Parkinson Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Centers for Advanced Research
|
|
University of Alabama
David Standaert, MD
Birmingham, AL
|
UCLA School of Medicine
Marie Francois Chesslet, MD, PhD
Los Angeles, CA
|
|
|
|
Emory University School of Medicine
Mahlon DeLong, MD
Atlanta, GA
|
The University of Chicago
Un Jung Kang, MD
Chicago, IL
|
|
|
|
Boston University School of Medicine
Marie St. Hilaire, MD
Boston, MA
|
Washington University Medical Center
Joel Perlmutter, MD
St. Louis, MO
|
|
|
|
Robert Wood Johnson Medical School
Jacob Sage, MD
New Brunswick, NJ
|
University of Pittsburgh
J. Timothy Greenamyre, MD, PhD
Pittsburgh, PA
|
|
|
|
University of Virginia Medical Center
Frederick G. Wooten, MD
Charlottesville, VA
|
|
|
|
